For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220204:nRSD6720Aa&default-theme=true
RNS Number : 6720A PureTech Health PLC 04 February 2022
PDMR DEALING NOTIFICATION
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Bharatt Chowrira
2 Reason for the notification
a) Position/status Director, President and Chief Business, Legal and Operating Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name PureTech Health plc
b) LEI 213800LVPDNO2Z9T9I39
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of PureTech Health plc
Identification code
ISIN GB00BY2Z0H74
b) Nature of the transaction Purchase of shares in market
c) Price(s) and volume(s) Price(s) Volume(s)
GBP 2.55 per share 20,000
d) Aggregated information
- Aggregated volume
Price Aggregate Volume
n/a n/a
- Price
e) Date of the transaction 3 February 2022
f) Place of the transaction London Stock Exchange (XLON)
ISIN GB00BY2Z0H74
b)
Nature of the transaction
Purchase of shares in market
c)
Price(s) and volume(s)
Price(s) Volume(s)
GBP 2.55 per share 20,000
d)
Aggregated information
- Aggregated volume
- Price
Price Aggregate Volume
n/a n/a
e)
Date of the transaction
3 February 2022
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBKNBNFBKDKBK